A critical advance in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital cancer protector protein is frequently disabled in several types of tumors, leading uncontrolled https://yesbookmarks.com/story22031273/vhh-fragments-reactivate-p53-the-promising-pathway-for-malignant-treatment